Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment of Safety and Effectiveness in Treatment Management of Atrial Fibrillation With the BWI IRE Ablation System (AdmIRE)

NCT05293639 is registered in ClinicalTrials.gov with Biosense Webster, Inc. as lead sponsor.

NCT NCT05293639
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05293639 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment of Safety and Effectiveness in Treatment Management of Atrial Fibrillation With the BWI IRE Ablation System (AdmIRE)
Lead sponsor
Biosense Webster, Inc.
Phase
Not applicable
Overall status
Completed
Start date
April 18, 2022
Completion date
December 11, 2023
Enrollment
362 (actual)
Sites
30

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation